We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AME icon
326
Ametek
AME
$55.5B
$3.56M 0.06%
49,192
+6,644
+16% +$463K
BCE icon
327
BCE
BCE
$19.9B
$3.55M 0.06%
73,746
+1,227
+2% +$58.4K
EW icon
328
Edwards Lifesciences
EW
$47.6B
$3.52M 0.06%
93,549
-972
-1% -$35.7K
SYY icon
329
Sysco
SYY
$39.7B
$3.51M 0.06%
57,844
-8,155
-12% -$462K
HPQ icon
330
HP
HPQ
$23.5B
$3.5M 0.06%
166,494
-3,011
-2% -$64K
FSLR icon
331
First Solar
FSLR
$21.8B
$3.47M 0.06%
+51,405
New +$3.01M
PARA
332
DELISTED
Paramount Global Class B
PARA
$3.46M 0.06%
58,705
+29,704
+102% +$1.71M
RARE icon
333
Ultragenyx Pharmaceutical
RARE
$2.65B
$3.43M 0.06%
74,000
+14,000
+23% +$686K
DE icon
334
Deere & Co
DE
$170B
$3.39M 0.06%
21,677
+1,906
+10% +$267K
OVV icon
335
Ovintiv
OVV
$17.5B
$3.39M 0.06%
50,598
-9,640
-16% -$569K
TFC icon
336
Truist Financial
TFC
$63.2B
$3.36M 0.06%
67,578
-3,027
-4% -$146K
WP
337
DELISTED
Worldpay, Inc.
WP
$3.36M 0.06%
+45,672
New +$3.26M
NTRS icon
338
Northern Trust
NTRS
$22.2B
$3.36M 0.06%
33,602
+1,172
+4% +$112K
SO icon
339
Southern Company
SO
$110B
$3.33M 0.06%
69,317
+1,866
+3% +$95.1K
BPMC
340
DELISTED
Blueprint Medicines
BPMC
$3.32M 0.06%
+44,000
New +$3.1M
GIS icon
341
General Mills
GIS
$19.2B
$3.31M 0.06%
55,765
+1,526
+3% +$82.5K
AFL icon
342
Aflac
AFL
$63.9B
$3.3M 0.06%
75,262
-108,596
-59% -$4.64M
MFC icon
343
Manulife Financial
MFC
$72.6B
$3.28M 0.06%
156,883
-1,605
-1% -$33.4K
ENB icon
344
Enbridge
ENB
$124B
$3.26M 0.06%
83,191
+8,821
+12% +$339K
BMO icon
345
Bank of Montreal
BMO
$125B
$3.25M 0.06%
40,463
+6,854
+20% +$534K
ECL icon
346
Ecolab
ECL
$75.6B
$3.25M 0.06%
24,201
-611
-2% -$81.3K
XEL icon
347
Xcel Energy
XEL
$51B
$3.23M 0.06%
67,170
+9,877
+17% +$490K
M icon
348
Macy's
M
$6.15B
$3.2M 0.06%
127,201
-538,075
-81% -$11.8M
CCI icon
349
Crown Castle
CCI
$32.7B
$3.2M 0.06%
28,797
+1,206
+4% +$130K
OKE icon
350
Oneok
OKE
$58.7B
$3.19M 0.06%
59,710
+14,777
+33% +$789K
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.